158 related articles for article (PubMed ID: 9425396)
21. Two years of replacement therapy in adults with growth hormone deficiency.
Verhelst J; Abs R; Vandeweghe M; Mockel J; Legros JJ; Copinschi G; Mahler C; Velkeniers B; Vanhaelst L; Van Aelst A; De Rijdt D; Stevenaert A; Beckers A
Clin Endocrinol (Oxf); 1997 Oct; 47(4):485-94. PubMed ID: 9404448
[TBL] [Abstract][Full Text] [Related]
22. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
Grumbach MM; Bin-Abbas BS; Kaplan SL
Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
[TBL] [Abstract][Full Text] [Related]
23. Hypokalaemia during insulin-induced hypoglycaemia in hypopituitary adults with and without growth hormone deficiency.
Davies JS; Hinds NP; Millward EM; McDowell I; Scanlon MF
Clin Endocrinol (Oxf); 1998 Aug; 49(2):217-20. PubMed ID: 9828910
[TBL] [Abstract][Full Text] [Related]
24. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Shalet SM
Clin Endocrinol (Oxf); 1999 Jun; 50(6):749-57. PubMed ID: 10468947
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.
Monson JP; Jönsson P; Koltowska-Häggström M; Kourides I
Clin Endocrinol (Oxf); 2007 Oct; 67(4):623-8. PubMed ID: 17581260
[TBL] [Abstract][Full Text] [Related]
26. Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency.
Gómez JM; Sahún M; Vila R; Domènech P; Catalina P; Soler J; Badimón L
Clin Endocrinol (Oxf); 2006 Jun; 64(6):632-9. PubMed ID: 16712664
[TBL] [Abstract][Full Text] [Related]
27. Immunoblot studies of the acid-labile subunit (ALS) in biological fluids, normal human serum and in children with GH deficiency and GH receptor deficiency before and after long-term therapy with GH or IGF-I respectively.
Labarta JI; Gargosky SE; Simpson DM; Lee PD; Argente J; Guevara-Aguirre J; Rosenfeld RG
Clin Endocrinol (Oxf); 1997 Dec; 47(6):657-66. PubMed ID: 9497872
[TBL] [Abstract][Full Text] [Related]
28. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
[TBL] [Abstract][Full Text] [Related]
29. Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency.
Janssen YJ; Doornbos J; Roelfsema F
J Clin Endocrinol Metab; 1999 Jan; 84(1):279-84. PubMed ID: 9920096
[TBL] [Abstract][Full Text] [Related]
30. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
[TBL] [Abstract][Full Text] [Related]
31. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism.
Beshyah SA; Thomas E; Kyd P; Sharp P; Fairney A; Johnston DG
Clin Endocrinol (Oxf); 1994 Mar; 40(3):383-91. PubMed ID: 8187303
[TBL] [Abstract][Full Text] [Related]
32. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.
Franco C; Johannsson G; Bengtsson BA; Svensson J
J Clin Endocrinol Metab; 2006 Nov; 91(11):4408-14. PubMed ID: 16940452
[TBL] [Abstract][Full Text] [Related]
33. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
[TBL] [Abstract][Full Text] [Related]
34. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis.
Johansson JO; Oscarsson J; Bjarnason R; Bengtsson BA
Metabolism; 1996 Mar; 45(3):362-9. PubMed ID: 8606645
[TBL] [Abstract][Full Text] [Related]
35. The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients.
Götherström G; Bengtsson BA; Sunnerhagen KS; Johannsson G; Svensson J
Clin Endocrinol (Oxf); 2005 Jan; 62(1):105-13. PubMed ID: 15638878
[TBL] [Abstract][Full Text] [Related]
36. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
[TBL] [Abstract][Full Text] [Related]
37. The effect of growth hormone (GH) replacement therapy in adult patients with type 1 diabetes mellitus and GH deficiency.
Christ ER; Simpson HL; Breen L; Sönksen PH; Russell-Jones DL; Kohner EM
Clin Endocrinol (Oxf); 2003 Mar; 58(3):309-15. PubMed ID: 12608936
[TBL] [Abstract][Full Text] [Related]
38. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
Isidori AM; Kaltsas GA; Perry L; Burrin JM; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
[TBL] [Abstract][Full Text] [Related]
39. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
Popovic V; Mattsson AF; Gaillard RC; Wilton P; Koltowska-Häggström M; Ranke MB
J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598
[TBL] [Abstract][Full Text] [Related]
40. The effects of human growth hormone (GH) administration in GH-deficient adults: a 20-day metabolic ward study.
Valk NK; vd Lely AJ; de Herder WW; Lindemans J; Lamberts SW
J Clin Endocrinol Metab; 1994 Oct; 79(4):1070-6. PubMed ID: 7525625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
